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The evolutionarily conserved JNK/AP-1 (Jun N-terminal kinase/activator protein 1) and BMP (Bone
Morphogenetic Protein) signaling cascades are deployed hierarchically to regulate dorsal closure in the
fruit ﬂy Drosophila melanogaster. In this developmental context, the JNK/AP-1 signaling cascade
transcriptionally activates BMP signaling in leading edge epidermal cells. Here we show that the mummy
(mmy) gene product, which is required for dorsal closure, functions as a BMP signaling antagonist.
Genetic and biochemical tests of Mmy's role as a BMP-antagonist indicate that its function is independent
of AP-1, the transcriptional trigger of BMP signal transduction in leading edge cells. pMAD (phosphory-
lated Mothers Against Dpp) activity data show themmy gene product to be a new type of epidermal BMP
regulator – one which transforms a BMP ligand from a long- to a short-range signal. mmy codes for the
single UDP-N-acetylglucosamine pyrophosphorylase in Drosophila, and its requirement for attenuating
epidermal BMP signaling during dorsal closure points to a new role for glycosylation in deﬁning a highly
restricted BMP activity ﬁeld in the ﬂy. These ﬁndings add a new dimension to our understanding of
mechanisms modulating the BMP signaling gradient.
& 2013 Elsevier Inc. All rights reserved.Introduction
The various forms of BMP (Bone Morphogenetic Protein)
signaling are conserved throughout evolution. In organisms from
ﬂies to mammals, BMPs (which belong to the TGF-β [Transforming
Growth Factor-β] superfamily of cytokines) function as essential
patterning effectors: most notably specifying dorsoventral axis
formation, maintaining stem cell niches in virtually all organisms,
and directing cartilage and bone formation, fracture repair, joint
maintenance and arthritic remodeling in vertebrates. The BMPs
have also been implicated in pathologies ranging from neurode-
generation to fertility defects (Affolter and Basler, 2007; Dansereau
and Lasko, 2008; Katsuno et al., 2011; Pogue and Lyons, 2006;
Shimasaki et al., 2004). Despite these wide-ranging and essential
BMP functions, many critical regulators of the pathway have yet to
be elucidated. In particular, relatively little is known of BMP
pathway modulation extracellularly, where the roles of proteins
affecting receptor stability, ligand function, and ligand availability
(such as proteoglycans, heparan and chondroitin sulfate modifyingll rights reserved.
etics, 15 N. 2030 E., Rm. 2100,
1 581 7796.
sou).
script.enzymes, and proteases) are only beginning to be identiﬁed and
understood, likely due to their shared participation in signaling by
multiple different ligands (Nishihara, 2010). The genetic and
molecular studies of mummy (mmy), which we describe here,
point to a role for the mmy-encoded UDP-N-acetylglucosoamine
pyrophosphorylase as a BMP antagonist that acts directly in
deﬁning both the amplitude and range of the BMP signaling
gradient. Within the context of dorsal closure in the fruit ﬂy
Drosophila melanogaster, themmy gene product plays a central role
in limiting embryonic epidermal BMP signaling. Moreover, Mmy
function as an enzyme affecting protein modiﬁcation by sugar
attachment points to potential new targets for the treatment of
BMP-associated developmental abnormalities and human disease
pathologies.
Sequential JNK/AP-1 and BMP signaling activities direct dorsal closure
In Drosophila, dorsal closure occurs midway through embry-
ogenesis when epidermal sheets, originally positioned ventrally
and laterally, extend to the dorsal midline where they meet and
fuse (reviewed in VanHook and Letsou, 2008). As the epidermis
secretes the larval cuticle, dorsal-open group mutants remain
uncovered by epidermis dorsally and accordingly secrete an
incomplete cuticle that is distinguished by a large dorsal hole.
Table 1
Dorsal-open group loci encoding signaling molecules and their hierarchical relationships.
A. JNK signaling molecules
slipper/slpr JNKKK
hemipterous/hep JNKK
basket/bsk JNK
Jun related antigen/Jra Jun transcription factor
kayak/kay Fos transcription factor
slpr hep bsk Jra/kay gene expression (dpp and puc)
B. Dpp signaling molecules
decapentaplegic/dpp TGF-β cytokine
thickveins/tkv TGF-β type I receptor
punt/put TGF-β type II Receptor
mothers against dpp/mad Smad transcription factor
schnurri/shn Zinc ﬁnger transcription factor
dpp-tkv/punt-mad and shn-gene expression
C. raw-group signaling antagonists
raw novel
puckered/puc MKP
ribbon/rib BTB/POZ-type transcription factor
mummy/mmy UDP-N-acetylglucosamine pyrophosphorylase
G.B. Humphreys et al. / Developmental Biology 381 (2013) 434–445 435The process of dorsal closure is dependent upon changes in cell
shape but not cell number; hence not unexpectedly, mutations in
several cytoarchitectural molecules give rise to defects in dorsal
closure. Many other dorsal-open group loci, however, code for
components of the JNK/AP-1 (Jun N-terminal kinase/activator
protein 1) or BMP signaling pathways, revealing these signaling
cascades as integral to and essential for this fundamental
morphogenetic event.
In dorsal closure, the JNK/AP-1 and BMP pathways act sequen-
tially. First, AP-1 functions as the transcriptional activator of dpp
(decapentaplegic; the Drosophila BMP homolog) in the dorsal-most
row of epidermal cells: the leading edge (LE). Later, Dpp is thought
to function in an autoregulatory fashion to maintain its own
expression in the LE (Johnson et al., 2003). Consistent with these
molecularly deﬁned roles, loss-of-function mutations in activating
components of the JNK/AP-1 and Dpp signaling cascades disrupt
signaling and consequently dorsal closure. In JNK/AP-1 and Dpp
signaling mutants (Table 1A,B), epidermal sheets fail to extend to
and fuse at the dorsal midline (reviewed in Xia and Karin, 2004).
At the opposite end of the spectrum is a small subset of dorsal-
open group loci, termed the raw-group, that lead not to the
absence of dpp in LE cells but rather to ectopic dpp in epidermal
cells beyond the LE (Table 1C). Whereas loss of Dpp signaling leads
only to dorsal cuticle holes, ectopic signaling leads to gross defects
in ventral cuticle differentiation in addition to dorsal cuticle
defects (Bates et al., 2008; Byars et al., 1999). Albeit clearly present,
the ventral cuticle that is secreted from raw-group mutants is
hypotrophic but neither mispatterned nor transformed, and con-
ceptually at least, raw-group genes can function as regulators of
either the JNK/AP-1 or Dpp signaling pathways.
Antagonizing signaling in embryonic dorsal closure
While our understanding of the JNK/AP-1 and Dpp signaling
activators in dorsal closure is bolstered by molecular and bio-
chemical studies in several systems, our understanding of the raw-
group signaling antagonists is not as extensive. puckered (puc) is
the best characterized of the three. puc codes for a VH1-like dual
speciﬁcity protein tyrosine phosphatase belonging to the mitogen-
activated protein kinase (MAPK) subfamily of MAP Kinase Phos-
phatases (MKPs) (Martin-Blanco et al., 1998). puc is required
throughout the Drosophila life-cycle; one of its earliest functions
is in LE cells during dorsal closure where it is transcriptionallyactivated by AP-1. It is thought that the Puckered MKP functions as
a negative feedback regulator, dephosphorylating and inactivating
Basket (Bsk), the JNK responsible for activating AP-1 in LE cells
(Martin-Blanco et al., 1998).
The action mechanisms of the two additional dorsal closure
signaling antagonists – raw (encoding a novel gene product; Byars
et al., 1999) and ribbon (rib; encoding a BTB/POZ-type transcription
factor; Bradley and Andrew, 2001; Byars et al., 1999; Shim et al.,
2001) – have yet to be deﬁned; although as is true for puc, raw-
mediated effects on dpp are secondary to its effects on JNK/AP-1
signaling (Bates et al., 2008; Bauer Huang et al., 2007).
Our previously published data (Bates et al., 2008; Byars et al.,
1999) indicate that the raw gene product functions broadly in the
epidermis to quench permissive AP-1 activity. Moreover, raw-
dependent suppression of epidermal AP-1 sets the stage for
LE-speciﬁc activation of AP-1 in LE cells of the epidermis.GlcNAc regulation of Dpp activity
In the current report, we show that mmy, originally isolated in
the Heidelberg screen for embryonic lethals affecting cuticle
pattern (Nusslein-Volhard et al., 1984), represents the newest
member of the raw-group of signaling antagonists. Within this
group, however, mmy function is unique. In contrast to the raw
and puc gene products, which restrict the signaling domain of Dpp
secondarily through their modulation of JNK/AP-1, mmy's effects
upon Dpp signal transduction are direct.
mmy codes for the single Drosophila UDP-N-acetylglucosamine
pyrophosphorylase, a key enzyme in UDP-N-acetylglucosamine
(UDP-GlcNAc) biosynthesis (Araujo et al., 2005; Schimmelpfeng
et al., 2006; Tonning et al., 2006). It is clear from previous reports
that mmy is required in Drosophila for the synthesis of extra-
cellular chitin (an insoluble polymer of GlcNAc), and that this
requirement manifests itself as cuticular and tracheal defects in
strong loss-of-function mmy mutants (Araujo et al., 2005; Devine
et al., 2005; Tonning et al., 2006). Chitin synthesis is, however,
unaffected in certain mmy hypomorphs including those exhibiting
defects in dorsal closure, and thus the dorsal-closure defects
observed in animals homozygous for these mmy hypomorphs are
thought to result from another requirement for UDP-GlcNAc
(Araujo et al., 2005; Schimmelpfeng et al., 2006; Tonning et al.,
2006).
G.B. Humphreys et al. / Developmental Biology 381 (2013) 434–445436In addition to being the building block of chitin, UDP-GlcNAc is
an essential precursor for the synthesis of heparin and chondroitin
sulfate proteoglycans, the former having been shown to play an
essential role in modulating the effects of Dpp/BMP, Wingless
(Wg)/WNT, and Hedgehog (Hh) morphogen signaling in Droso-
phila and other eukaryotes, usually as a facilitator of long-range
signaling (Akiyama et al., 2008; Beckett et al., 2008; Belenkaya
et al., 2004; Capurro et al., 2008; Gallet et al., 2008; Gumienny
et al., 2007). Evidence presented in the current report points to a
new role for GlcNAcylation in modulating Dpp activity. Our results
demonstrate that Mmy/UDP-GlcNAc constrains rather than facil-
itates epidermal Dpp signaling during closure, presumably by
limiting the signaling capacity of the Dpp cytokine that is
produced in LE epidermal cells.Materials and methods
Drosophila strains
Fly lines for this study include mmy1, mmyP15133, raw1, aop1,
bsk2, JraIA109, pucH246, rib1, Df(2L)BSC6, UAS-brk and 69B-gal4
(Marygold et al., 2013), as well as mmyLM1, mmy LM16, mmyLM24,
mmyLM45, mmyLM47 and mmyLM51 (M. Krasnow), and pucE69
(A. Martinez-Arias).
Phenotypic analyses
Embryonic lethal cuticle phenotypes were viewed after mount-
ing samples in one-step mounting medium (30% CMCP-10, 13%
lactic acid, 57% glacial acetic acid). For hybridizations in situ, we
used digoxigenin-labeled RNA as described (Byars et al., 1999);
with mouse anti-digoxigenin alkaline phosphatase or mouse anti-
digoxigenin (Roche). For immunostains, we used rabbit anti-Jun
(Santa Cruz Biotechnology), rabbit anti-Phospho-Smad1,5 Ser463/
465 (Cell Signaling Technology), mouse anti-β-Gal (Promega), goat
anti-mouse alkaline phosphatase (Promega), goat anti-rabbit alka-
line phosphatase (Jackson ImmunoResearch), and goat anti-rabbit
Alexa Fluor 488 antibodies (Invitrogen Molecular Probes).
RT-PCR
Mutant homozygotes were distinguished from wild-type sib-
lings 4–8 and 8–12 h AEL (after egg lay) based on the absence of a
GFP (Green Fluorescent Protein)-marked balancer chromosome.
RNA was isolated from wild-type and mutant embryos, and
reverse transcripts generated using a dT16 primer. PCR products
were generated using RA- and RB- speciﬁc 5′primers in combina-
tion with an exon two 3′primer.
Protein studies
For immunoblotting studies, proteins were prepared from
experimental and control lysates 8–12 h AEL. Mutant homozygotes
were distinguished from wild-type siblings based on the absence
of a GFP-marked balancer chromosome. CIP (Calf Intestine Alkaline
Phosphatase) was added to half-portions of each lysate. Treated
and untreated lysates were separated on SDS-acrylamide gels and
analyzed by western blotting using anti-Jun antibody. The sec-
ondary antibody was HRP-conjugated goat anti-rabbit antibody
(Chemicon). Jun densitometry values were calculated as ratios of
experimental to control band integrated intensities (the product of
mean band intensity and pixel number in an inverted image) and
normalized to wild-type CIP-treated and untreated ratios. Similar
methods were used to quantify pMAD in the dorsal lateral
epidermis of wt and mmy1 embryos. The number of pMAD-positive nuclei in the dorsolateral epidermis were counted in
columns of cells in T1, T3, A4 and A6 in wt and mmy1 embryos
(n¼14 and 11 embryos, respectively). pMAD-positive nuclei were
counted in the middle and posterior of each segment in all
embryos. Short (middle) and long (posterior) column depths were
averaged for each embryo.
Yeast transformation and rescue
Rescue studies were performed in qri1 Saccharomyces cerevi-
siae. Diploid ura3 yeast strains harboring a heterozygous KanMX4
insertion in QRI1 were transformed with the mmy-RA+ URA3
expression plasmid (constructed by insertion of the full-length
mmy RA cDNA into p426-ADH1). After transformation, yeast cells
prototrophic for uracil were induced to sporulate by standard
methods and tetrads dissected by micromanipulation. Rescue of
qri1 lethality was determined by assessing growth on CM-ura, YPD
+G418, and YPD+5-FOA agar plates.Results
Mummy functions as an N-acetylglucosamine pyrophosphorylase
The Drosophila genome encodes a single UDP-N-
acetylglucosamine pyrophosphorylase (mummy [mmy]), which
potentially functions in the synthesis of saccharides as well as
the modiﬁcation of multiple glycosylated protein and lipid pro-
ducts (Fig. 1A). Two transcript isoforms (RA and RB) are derived
from themmy locus. The RB isoform is homologous along its entire
length to the eukaryotic family of UDP-N-acetylglucosamine
pyrophosphorylases; the RA isoform, in contrast, encodes a dis-
tinctive amino terminus, the result of a splice form variant created
by use of an alternative 5′ exon (Fig. 1B). The RA amino terminus
comprises a 37 amino acid stretch that has yet to be identiﬁed in
genome scans of any sequenced organism other than members of
the genus Drosophilidae. Except for the species willistoni, the
sequence is highly conserved in all members of the subgenus
Sophophora (Fig. 1C).
While our current understanding of the genome does not allow
us to predict how the unique 5′ end of the mmy RA isoform affects
its enzymatic function, we show here that the RA-encoded protein
product retains N-acetylglucosamine pyrophosphorylase activity
in a heterologous rescue assay. A plasmid with the Drosophila
mmyRA+ gene fully restores viability to a S. cerevisiae strain with a
disruption in the essential QRI1 gene (the yeast mmy homolog;
Fig. 1D). A diploid ura3 yeast strain harboring a heterozygous
KanMX4 insertion in QRI1 was transformed with the mmy-RA+
URA3 expression plasmid. Transformation resulted in uracil pro-
totrophy, as indicated by qri1+ and qri1− spore survival on
complete medium lacking uracil (CM-ura). Whereas transformed
qri1+ spores cannot grow on medium supplemented with the drug
G418 (YPD+G418), transformed qri1− spores grow well in the
presence of G418, indicating that the KanMX4 insertion remains
in qri1− spores after transformation. Finally, transformed qri1−, but
not qri1+, spore viability is dependent upon the presence of mmy-
RA+ URA3 expression plasmid as only qri1+ spores survive expo-
sure to 5-FOA (which elicits plasmid loss). Together, these data
indicate that qri1− viability is dependent upon presence of the
mmy-RA+ URA3 expression plasmid and show that the Drosophila
mmy RA gene product is an orthologue of the yeast
N-acetylglucosamine pyrophosphorylase QRI1. Thus, as is the case
for the human and Candida albicans QRI1 loci (51% and 41%
identical and 70% and 60% similar to Drosophila mmy, respec-
tively), the novel Drosophila mmy RA isoform rescues the lethal
phenotype associated with the S. cerevisiae qri1 null mutation
Fig. 1. Organization and expression of the mmy gene. (A) Schema for the generation of UDP-GlcNAc from glucose. In Drosophila there are at least 26 transferases (Correia
et al., 2003), each of which can catalyze the transfer of GlcNAc from UDP-GlcNAc to a subset of acceptors. The transferase-dependent step is marked (n). (B) Intron-exon map
of RA and RB mmy isoforms. (C) Cladistic analysis of the protein sequences encoded by RA exon 1. (D) A diploid ura3 yeast strain harboring a heterozygous KanMX4 insertion
in QRI1 was transformed with the mmy-RA+ URA3 expression plasmid; the growth properties of four spores derived from a single tetrad are shown.
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et al., 1998).
mmy expression is dynamic in Drosophila embryos
In addition to employing alternative ﬁrst exons, RA and RB mmy
isoforms also differ in their transcriptional regulation. Whereas RAtranscript levels are invariant in wild-type embryos, RB transcript
levels are low in wild-type embryos 4–8 h AEL but greatly elevated
a short time later, 8–12 h AEL (Fig. 2A). During this period, the
embryo develops trachea and undergoes dorsal closure. Despite
conﬂicting descriptions of mmy expression in the literature
(Araujo et al., 2005; Tonning et al., 2006), our strictly temporal
analysis of mmy gene expression in RT-PCR studies provides clear
Fig. 2. Pleiotropic effects ofmmy. (A) Temporal proﬁle ofmmy transcription in early embryogenesis. RA and RB transcripts were distinguished and quantiﬁed by RT-PCR using
RNAs isolated fromwild-type and mutant (mmy1and mmy P15133, here abbreviatedmmyP) embryos 4–8 and 8–12 h AEL. GAPDH RNA levels are shown as a control for loading.
(B–E). Spatial proﬁle of mmy transcription in hybridizations to whole mount embryos in situ using a digoxigenin-labeled mmy RNA as probe: (B) syncytial blastoderm,
(C) germ band extension, (D) germ band retraction, and (E) dorsal closure. In contrast to the asymmetrically patterned cuticle that is derived from (F) wild-type embryos, (G)
mmyP15133 homozygotes and (H) mmyP15133/Df (3R)345 transheterozygotes fail to secrete cuticle (and the preps have not been devitellinized). Hypomorphic mmy mutations
lead to shared loss-of-function phenotypes with mutations in genes that modulate JNK and/or Dpp signaling pathways: (I) raw1, (J) mmy1, (K) mmyLM24, (L) aop1, (M)
mmyLM51, and (N) mmyLM45.
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esis. Complementing our temporal expression data are spatial
expression data derived from in situ hybridization studies
(Fig. 2B–E). These studies extend previously published reports
(Araujo et al., 2005; Tonning et al., 2006) in revealing mmy
expression to be dynamic spatially, as it is temporally, throughout
embryogenesis. We found that mmy is expressed ubiquitously and
uniformly in the cellular blastoderm. However, even though
ubiquitous mmy expression persists throughout embryogenesis,
transcript accrual at later developmental time points is spatially
partitioned. We noted mmy accumulations in the developing
mesoderm, gut primordia, and trachea. Overall, widespread
mmy expression reveals its potential to function in multiple
aspects of Drosophila embryonic development, consistent with
its role as the single UDP-N-acetylglucosamine pyrophosphorylase
in Drosophila.
mmy is essential for multiple developmental events in Drosophila
The sequence and regulatory differences that characterize the
two mmy transcripts, as well as the spatially broad and dynamic
mmy expression proﬁle, suggest that mmy function is pleiotropic.
Although only the mmy-dependent chitin defects have been
characterized in detail (Araujo et al., 2005; Tonning et al., 2006),
results from our genetic studies are consistent with the idea thatthe mmy-encoded N-acetylglucosamine pyrophosphorylase
impacts multiple Drosophila developmental events via the action
of several different downstream transferases, some of which
modify proteins and lipids with GlcNAc (see Fig. 1A).
Independently-derived mmy mutants exhibit a variety of highly
penetrant phenotypes, ranging from cuticle defects associated
with a failure to synthesize chitin (Fig. 2F–H) to cuticle defects
associated with well-characterized Dpp-dependent closure
abnormalities (dorsal closure and head involution; Fig. 2I–N). In
particular, these mmy-associated cuticle defects are identical to
those resulting from loss-of-function mutations in raw and
anterior-open (aop), and point to a crucial role for Mmy in
regulating embryonic Dpp signaling.
Absence of cuticle is thus far the best characterized of the mmy
phenotypes and clearly results from deﬁciencies in chitin synth-
esis (Araujo et al., 2005; Schimmelpfeng et al., 2006; Tonning
et al., 2006). We have used two independent strategies to show
that the cuticleless phenotype deﬁnes the strongest loss of zygotic
function condition. First, we conﬁrmed that the cuticleless
mmyP15133 allele harbors a transposon insertion within mmy's
second intron and demonstrated that the insertion affects
transcription of the RA and RB transcripts, both being markedly
reduced in mmyP15133 homozygotes in comparison to wild-type
controls (Fig. 2A). More notably, we demonstrated that
the mmyP15133/mmyP15133 embryonic lethal cuticular phenotype is
Fig. 3. mmy-mediated restriction of Dpp signaling during closure. pMAD
immunolocalization in whole mount wild-type (wt) and mmy1 (mmy) mutant
embryos in (A,B) germ band extended, (C,D) germ band retracting, and (E–G)
dorsal closure stages of embryogenesis. (H–L) Immunolocalization of pMAD in
wild-type (wt), and mmy1 (mmy) embryos imaged by laser scanning microscopy
with (I,J) representing single focal planes and (K,L) corresponding to compila-
tions of multiple Z-stacks. (M) Quantitation of epidermal pMAD immunostain
intensities in wt and mmy embryos at dorsal closure. Values were calculated as
experimental (n¼17 for wt and n¼13 for mmy) to wt ratios of background-
corrected integrated intensities in inverted images of whole-mount embryos. n
indicates that the calculated wt and mmy values are statistically different
(p¼710−6), while error bars correspond to the conﬁdence interval of the
mean (po0.05). (N) Quantitation of spatial extent of pMAD immunostain in the
epidermis of wt and mmy embryos at dorsal closure; measurements were
obtained from the shortest (middle) and longest (posterior) pMAD-staining
region of each segment. n indicates the calculated wt and mmy values are
statistically different (po1.610−10), while error bars correspond to the
conﬁdence interval of the mean (po0.05).
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zygotes and thus genetically deﬁned the mmyP15133 allele as null
(Fig. 2G,H).
While there is no redundancy in the biosynthetic pathway
leading to the generation of UDP-GlcNAc, GlcNAc itself is distrib-
uted to distinct protein targets via the action of several different
downstream UDP-GlcNAc transferases. Hence, even as the mmy
null condition reveals much about the central role for GlcNAc in
chitin synthesis, it likely masks other equally important, albeit
independent, mmy-dependent GlcNAcylation processes. To help us
understand one of these additional roles for mmy and GlcNAc
more fully, we turned our attention to the Class III mmy mutants
that as a group were characterized previously as strong loss-of-
function mutants sometimes associated with dorsal closure
defects (Devine et al., 2005). mmy1, a focus of the studies
described here, is predicted from sequencing studies to be a
regulatory mutant; indeed, the RB transcript is speciﬁcally
affected, showing a 3-fold reduction 8–12 h AEL, corresponding
to the time whenmmy1 mutants abort development due to defects
in dorsal closure (Fig. 2A). Our sequencing studies revealed that
the mmy1 coding region harbors neither missense nor nonsense
mutations (data not shown). Other mmy alleles showing a high
penetrance of dorsal closure and ventral cuticle defects are
mmyLM1, mmyLM16, and mmyLM24. Respectively, these alleles harbor
missense mutations in the mmy-encoded N-acetylglucosamine
pyrophosphorylase substrate-binding site (S204L) and the dipho-
sphorylase consensus motif (G150S; G148R) (Devine et al., 2005).
Mmy antagonizes Dpp signaling
The mmy dorsal-open, ventral-hypotrophic cuticle phenotypes
(see Fig. 2J,K) led to our speculation that Mmy-dependent glyco-
sylation might be integral to restriction of Dpp signaling during
closure. In particular, we noted that in all closure-defective mmy
mutants, dorsal closure defects do not appear in isolation but
rather are associated with ventral cuticular defects that we and
others have shown previously to be associated with ectopic Dpp
(Bates et al., 2008; Byars et al., 1999; Riesgo-Escovar and Hafen,
1997). We employed molecular and functional experimental
strategies to test the hypothesis that Mmy is required to limit
Dpp signaling in the embryonic epidermis of Drosophila.
First, we directly visualized embryonited [activated] form of the
Dpp signal transc epidermal Dpp activity. To do this, we used an
antibody directed against pMAD (the phosphoryladucer Mothers
against dpp) in conjunction with both DIC (differential interfer-
ence contrast) and confocal imaging methods. Using DIC, we
detected pMAD very broadly in the epidermis of wild-type
embryos undergoing germ band extension (Fig. 3A); later in
development (in germ band retracting stages of embryogenesis),
we observed diminution of the pMAD immunoreactive domain
(Fig. 3C). Attenuation of the Dpp signaling amplitude is most
evident at dorsal closure. We detected pMAD staining at levels
only modestly above background in the dorsal epidermis of 48% of
dorsal-closure stage embryos and no pMAD in the dorsal epider-
mis of 52% of dorsal-closure stage embryos (n¼219; Fig. 3E,G). Our
pMAD immunoreactivity proﬁle data point to a previously unrec-
ognized tissue-speciﬁc Dpp signaling transition in the epidermis of
wild-type, dorsal-closure stage embryos – from widespread and
robust in germ band extended stages to restricted and then
undetectable in dorsal closure stages.
When we examined the epidermal Dpp signaling domain in
mmy mutant embryos, we found that although germ band
extended and retracted pMAD proﬁles are similar in wild-type
and mmy mutant embryos (Fig. 3B,D), differences are evident later
in development. Dpp signaling, which is attenuated in dorsal
closure stages of wild-type embryogenesis, persists temporally
G.B. Humphreys et al. / Developmental Biology 381 (2013) 434–445440and extends spatially in similarly staged mmy mutants (Fig. 3F). In
100% of dorsal-closure stage mmy embryos, pMAD remains
robustly expressed in the dorsal epidermis at levels ∼3-fold higher
than that observed in the pMAD-positive fraction of wild-type
embryos (Fig. 3M). Analysis of wild-type and mutant embryos by
confocal microscopy not only validated the genotype-associated
spatio-temporal differences in Dpp signaling that we documented
previously by DIC microscopy, but also provided a platform for
quantiﬁcation of spatial differences (Fig. 3H–L,N). We observed
that while pMAD immunoreactivity can extend to an average
depth of ﬁve epidermal cells in some dorsal closure stage wild-
type embryos, immunoreactivity extends to an average depth of
ten epidermal cells in all similarly staged mmy mutants.
Having established that pMAD persists broadly in the epider-
mis of dorsal closure stage mmy embryos, we next applied
functional tests to assess whether Dpp gain-of-function is causa-
tive of developmental abnormalities in mmy mutants. To this end,
as epidermal Dpp can be autoregulatory (Arora et al., 1995;
Johnson et al., 2003), we compared epidermal dpp expression
proﬁles in wild-type and mutant (mmy1 and mmyLM16) whole
mount embryos in situ. In wild-type embryos, from germ band
extended to germ band retracted stages of development, we
observed epidermal dpp only in LE cells (Fig. 4A–C). In contrast,
in similarly staged dorsal-open mmy mutants we observed ectopic
dpp transcription in the embryonic epidermis (Fig. 4D–F), analo-
gous to that which we documented previously in raw and raw-
group mutant embryos (Fig. 4L; see also Bates et al., 2008). Thus,
as for other members of the raw-group, in mmy mutants a poorly
differentiated cuticle is linked to expansion of the epidermal dpp
expression domain.Fig. 4. Ectopic Dpp signaling in mmy mutants is causative of developmental abnormali
mount embryos: (A,D) germ band extended, (B,E) germ band retracting, and (C,F) dors
JraIA109 mmy1, and (L) raw1, dorsal closure stage embryos. Expression of the pucE69 enh
closure. (M,N) brinker expression in wild-type and mmy1 homozygotes; (O) rescued ven
with an arrow.Next, we employed the UAS-GAL4 system to express the well-
characterized dpp antagonist brk in the ectopic epidermal Dpp
signaling domain of mmy mutants (Brand and Perrimon, 1993;
Scuderi and Letsou, 2005). Cuticles derived from mmy1/mmy1;
UAS-brk/69B-gal4 transgenics revealed rescue of mmy1-dependent
defects; particularly clear was the restoration of ventral denticles
to the cuticle (Fig. 4O; see also Fig. 2J for mmy1/mmy1 mutant
comparison). It is notable that the brk and dpp domains are neither
overlapping nor abutting in wild-type embryos undergoing dorsal
closure (Jazwinska et al., 1999). Moreover, the brk expression
domain is not altered in mmy mutants (Fig. 4M,N). Together, our
Dpp/dpp localization and brk suppression data show that Dpp
activity expands in mmy mutants and is causative of develop-
mental abnormalities.
Mmy modulation of Dpp signaling is Dpp-dependent and
AP-1-independent
We next sought insight into the molecular basis of Mmy-
mediated antagonism of Dpp signaling. Given our understanding
of Dpp/dpp regulation during dorsal closure as well as in other
developmental contexts, we speculated that mmy might restrict
epidermal Dpp signaling: (1) in an established manner (e.g. like
raw and puc), transcriptionally via JNK/AP-1-mediated restriction
of dpp gene activation, or (2) in a novel manner (with respect to
the LE and epidermis), post-transcriptionally via restriction of
autoregulatory Dpp signaling activity.
We employed several strategies to discriminate between tran-
scriptional and post-transcriptional models of Mmy function as a
Dpp signaling antagonist. First we assayed whether ectopicties. dpp mRNA transcript expression in wild-type (wt) and mutant (mmy1) whole
al closure stages of embryogenesis. dpp expression is also shown in (J) JraIA109, (K)
ancer trap in (G) wild-type, (H) mmy1, and (I) raw1 mutant embryos during dorsal
tral cuticle in mmy1; UAS-brk/69B-Gal4 transgenics. In all panels, the LE is indicated
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whether other transcriptionally regulated LE targets of JNK/AP-1
are ectopically expressed as well. In addition to dpp, there is
another well-characterized transcriptionally-regulated target of
JNK/AP-1 activation in the LE during closure – puc. As is true for
dpp, puc transcription is abolished in LE epidermal cells in
embryos harboring mutations in JNK/AP-1 signaling activators,
including hep (JNKK), bsk (JNK), and Jra (Jun) (Glise and Noselli,
1997), and expanded in embryos mutant for JNK signaling antago-
nists raw and puc (MKP) (Byars et al., 1999; Ring and Martinez
Arias, 1993).
We used the well-characterized JNK/AP-1 responsive puc
enhancer trap (pucE69-lacZ) to monitor LE puc expression. As we
and others have reported previously, we observed β-Gal activity
that temporally and spatially mirrors LE dpp expression in wild-
type animals (Byars et al., 1999; Dobens et al., 2001; Stronach and
Perrimon, 2001); in this regard, we detected β-Gal initially in the
LE of germ band extended embryos and we observed its persis-
tence in LE cells throughout dorsal closure stages of development
(Fig. 4G). In mmy mutants, β-Gal never expanded beyond the LE
epidermal domain as it does in raw and puc mutant embryos
(Fig. 4H,I; see also Byars et al., 1999). Our observation that mmy-
mediated expansion of dpp gene expression does not extend to a
second transcriptionally-regulated target of JNK/AP-1 in LE cells
(puc) suggests that ectopic dpp transcription in mmy mutants is
not a consequence of ectopic AP-1 activity.
Next, we employed biochemical methods to examine Jun in
wild-type and mutant embryos directly. For initial measures of
Jun/AP-1 activity in wild-type and raw-group mutant embryos, we
identiﬁed an anti-Jun antibody that recognizes endogenous Dro-
sophila Jun protein in extracts isolated from wild-type embryos
(Fig. 5A). In comparisons of phosphatase-treated and untreatedFig. 5. JNK signaling is normal in mmy mutants, but not in raw mutants. (A) Anti-Jun an
derived from JraIA109 mutants. (B) Anti-Jun antibody recognizes a doublet in untreated ex
(C) mmy1, and (D) raw1 and bsk2 mutant embryos. Total Jun protein was quantiﬁed, an
Controls for protein loading equivalency are shown for all gels where protein was quanti
embryos imaged by laser scanning microscopy with no (top row) and 2.5x (bottom row
epidermis, and EP denotes epidermis.lysates, we identiﬁed phosphorylated (activated) and unpho-
sphorylated (inactivated) Jun isoforms (Peverali et al., 1996). In
wild-type embryos, both the phosphorylated and unphosphory-
lated isoforms are present (Fig. 5B). Immunoblotting studies
indicated that the wild-type balance between phosphorylated
and unphosphorylated Jun isoforms is unchanged in mmymutants
(Fig. 5C), demonstrating that overall embryonic phosphorylated
and unphosphorylated Jun levels are not detectably altered in this
quantitative assay. In contrast though, levels of phosphorylated
and unphosphorylated Jun are altered considerably in rawmutants
(Fig. 5D). Not only is the unphosphorylated Jun isoform undetect-
able in non-CIP treated extracts from raw1 (null) mutant embryos,
but the more slowly migrating phosphorylated isoform accumu-
lates to measurably higher levels in raw1 and raw1 bsk2 double
mutant embryos than it does in wild-type embryos (more than
2-fold for both). This observation, as well as a parallel immuno-
blotting analysis of extracts from bsk2 nulls revealing a pattern of
Jun phosphorylation that is indistinguishable from that of wild
type, is consistent with our previous strictly genetic prediction
that the majority of Jun phosphorylation in wild-type embryos is
dependent upon a Jun kinase other than zygotic Basket, and that
Raw antagonizes the function of this kinase (Bates et al., 2008).
Immunolocalization studies in mmy and raw mutant embryos
complemented western studies and further bolstered our conclu-
sion that Raw mediates dpp antagonism via its function upstream
of Jun, while Mmy-mediated dpp antagonism likely occurs down-
stream. From immunolocalization studies, it is clear that: (1) Jun is
expressed broadly in wild-type and mutant (mmy1 and raw1)
embryos, and (2) Jun does not differentially accumulate in LE cells
from raw embryos as it does in mmy and wild-type dorsal-closure
stage embryos (Fig. 5E–H). Thus, biochemical markers of pheno-
type, in conjunction with molecular markers, indicate that mmy istibody recognizes wild-type protein but not a truncated version lacking the epitope
tract but a singlet in extract treated with CIP. Jun modiﬁcation and accumulation in
d measurements relative to wild-type are reported at the bottoms of panels C,D.
ﬁed. Immunolocalization of Jun in (E) wild-type, (F) JraIA109, (G) mmy1, and (H) raw1
) zoom. In 2.5x zoomed images, A denotes Amnioserosa, LE denotes leading edge
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antagonize Dpp indirectly through their function as Jun pathway
modulators, the effects of mmy are downstream of the Jun path-
way and likely target the Dpp pathway directly.
Finally, having established that mmy-dependent defects in
closure effects are Jun-independent, we used mutants in the
JNK/AP-1 signaling pathway to speciﬁcally ablate LE dpp and to
test whether mmy-dependent defects in dorsal closure are depen-
dent upon LE dpp. While we detect dpp ectopically in the
epidermis of mmy mutant embryos, its expression is absent from
the epidermis of mmy Jra and mmy bsk double mutants as it is also
in Jra and bsk single mutant backgrounds (Fig. 4J,K and data not
shown). Our demonstration that null mutations in either Jra or bsk
prevent manifestation of the ectopic dpp phenotype associated
with mmy1 indicates that Jun is the lone transcriptional trigger of
epidermal dpp in both wild-type and mmy mutant embryos, and
even more notably that LE JNK/AP-1-dependent dpp expression is
a prerequisite for the expansion of epidermal dpp that we observe
in dorsal-open mmy mutants. Thus, mmy’s effects are Dpp-
dependent. Viewed from the perspective of mechanism, results
from our studies point to a role for Mmy in shaping and
constraining the epidermal Dpp gradient.Discussion
In the current report, we provide signiﬁcant new insights into
the mechanisms by which morphogen activity domains are
spatially constrained in development. Although secreted Dpp/
BMP is a potent and largely unconstrained morphogen in most
developmental contexts, in the Drosophila embryonic epidermis
dpp/Dpp expression and function are precisely regulated in time
and space. Results from studies reported here and elsewhere
reveal that at least two tiers of signaling antagonism contribute
to this spatio-temporal restriction. In particular, we show that JNK/
AP-1 and Dpp regulatory machineries function independently to
limit bioactive Dpp signaling ﬁelds in the Drosophila embryonic
epidermis. Whereas widespread transcriptional activation of epi-
dermal dpp is suppressed by Raw, long-range Dpp signaling is
suppressed by Mmy. Thus, Mmy and Raw, despite their striking
shared loss-of-function phenotypes, independently constrain the
amplitude and range of Dpp activity during dorsal closure. More-
over, the Mmy and Raw pathways are not redundant, as loss of
either leads to ectopic Dpp activity.
mmy, which encodes the Drosophila UDP-N-acetylglucosamine
pyrophosphorylase, represents the fourth and newest member of
the raw-group of dorsal-open mutants. As we showed previously
for the three deﬁning members of this group (raw, puc, and rib;
Bates et al., 2008), mmy mutant's exhibit: (1) defects in two Dpp-
dependent embryonic processes – dorsal closure and ventral
cuticle differentiation, as well as (2) expansion of epidermal Dpp
activity. mmy is, however, distinct from the two members of the
raw-group whose modes of action have been deﬁned previously.
Speciﬁcally, we have demonstrated that unlike the novel raw
protein and the Puckered MKP, which mediate their effects on
Dpp via their modulation of a JNK/AP-1 signaling cascade,
Mmy mediates restriction of Dpp activity directly. Moreover, our
data provide strong evidence that a target of the mmy-encoded
UDP-N-acetylglucosamine pyrophosphorylase functions as a
developmental switch in the Drosophila epidermis, eliminating
long-range Dpp signaling.
Modulation of Dpp signaling activity by Mmy and UDP-GlcNAc
Dpp signaling has been exceptionally well characterized in
patterning Drosophila embryos and imaginal discs (O′Connor et al.,2006). A key feature of Dpp action in these two developmental
contexts is that Dpp exerts its effects on immediate neighbors, as
well as on more distant cells, via an extracellular morphogen
gradient. Based on these clear and strong precedents, it has been
widely assumed that during dorsal closure Dpp is secreted from its
LE cell source and subsequently functions non-cell autonomously
to direct cell changes in the lateral epidermis that are essential for
Drosophila morphogenesis during dorsal closure (Fernandez et al.,
2007). Evidence from studies presented here and elsewhere
(Wang et al., 2008) have, however, led us to a new model of Dpp
function in LE cells during closure. As discussed below, it is now
apparent that during dorsal closure LE Dpp does not function
exclusively as a long-range epidermal signal. Moreover, long-range
epidermal Dpp signaling is constrained during dorsal closure, and
the mmy gene product plays a central role in reﬁning this vital
epidermal Dpp activity proﬁle.
Our studies have their foundation in the observation that
embryos homozygous for several mmy alleles (mmy1, mmyLM1,
mmyLM16, mmyLM24) suffer a fully penetrant embryonic lethality
associated with a cuticle phenotype that we have shown here and
elsewhere (Byars et al., 1999) is due to misregulated Dpp signaling
– spatially, temporally, and quantitatively. Moreover, our data lead
us to suggest that Dpp secreted from LE epidermal cells encoun-
ters an as yet unidentiﬁed sugar-modiﬁed sink. For example,
Mmy-dependent modiﬁcation of either an ECM or Dpp receptor
component might constrain Dpp activity (by either degradation or
titration). In contrast, we suspect that in the absence of mmy, Dpp
sequestration is down-regulated and Dpp is consequently free to:
(1) move away from its source, and (2) generate the expanded and
more robust signaling ﬁeld that we visualize in epidermal dpp/Dpp
expression and activity proﬁles (Fig. 6).
Somewhat contrary to the established paradigm of Glc-NAc/
glypican function in modulating Dpp signaling in the wing disc of
Drosophila, we found that Mmy limits rather than augments the
Dpp signaling ﬁeld in the embryonic epidermis. There is prece-
dence for opposing effects of glypicans in Hedgehog signaling,
where the sugar modiﬁcation has been shown to augment signal-
ing in Drosophila while down-regulating signaling in mouse
(Beckett et al., 2008). In addition, and although not previously
recognized as such, our current studies, along with previous
studies focusing on LE dpp transcription (Arora et al., 1995;
Johnson et al., 2003; Letsou et al., 1995), indicate that the
embryonic epidermis is competent to regulate dpp in an auto-
regulatory fashion as it is in several other developmental contexts
(Capovilla et al., 1994; Hursh et al., 1993; Panganiban et al., 1990;
Staehling-Hampton and Hoffmann, 1994). Thus, epidermal signal-
ing abnormalities in mmy mutants can be ampliﬁed via a feed
forward mechanism of intercellular communication. Moreover, in
this context at least, cytokine diffusion represents the default
state. Finally, it is notable that while pMAD activates dpp tran-
scription beyond the leading edge in mmy mutant embryos, the
more modest amounts of pMAD visualized in dorsal-closure stage
wild-type embryos are insufﬁcient to activate dpp transcription in
these same cells. Quantitation of this difference in wild-type and
mmy mutant embryos deﬁned a three-fold threshold for dpp-
activation by pMAD.
Future experiments will require identiﬁcation of the
Mmy-dependent glycosylated protein product(s) essential for
Dpp restriction to LE cells. Certainly there are several potential
candidates; very high among these are Dpp receptors (and co-
receptors). Both Tkv and Punt, the type I and type II receptors
functioning in dorsal closure, harbor multiple potential glycosyla-
tion sites; modiﬁcation of any of these might enhance ligand
afﬁnity for its receptor. The type I Dpp receptor Tkv has been
shown previously to be a means for Dpp signal down-regulation
(Lecuit and Cohen, 1998), and the type II Dpp receptor has been
Fig. 6. Modeling LE dpp restriction. JNK/AP-1 and Dpp signaling in LE cells is shown at top. Dorsolaterally-positioned epidermal cells are shown below: (A) In wild-type cells,
raw prevents accumulation of the bioactive, phosphorylated form of Jun in the dorsolateral epidermis, while mmy prevents Dpp from signaling between LE and neighboring
epidermal cells. (B) In mmy mutants, LE Dpp activates signaling in neighboring epidermal cells, where autoregulatory dpp feeds forward to activate its own transcription.
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signaling pathway (Simin et al., 1998). Collagen might also be
modiﬁed by GlcNAc as it has been suggested that the Drosophila
collagen Viking sequesters and limits the Dpp signaling range in
the germarium (Wang et al., 2008). The Dally or Dally-like
glypicans, although augmenting Dpp diffusion rates at previously
deﬁned sites of Dpp action in Drosophila and also play limiting
roles in restricting the movement of a morphogen signal in other
organisms (Gumienny et al., 2007), are not likely to function
downstream of Mmy in regulating epidermal signal transduction.
Loss-of-function dally or dally-like mutations are associated with
neither dorsal closure defects nor embryonic lethality more gen-
erally. In addition, dally and dally-like double mutant studies with
mmy show no genetic interactions (GH, unpublished). Finally, it is
possible that Mmy contributes to the modiﬁcation of intracellular
proteins or chromatin through O-linked glycosylation. We do not
favor this mechanism of action as the effect that we see is
dependent upon leading edge dpp expression, and this strongly
implicates signaling itself as the Mmy-dependent step in Dpp
regulation. Moreover, as for dally and dally-like, loss of function
mutations of the single O-linked transferase in Drosophila are not
associated with defects in dorsal closure (Ingham, 1984).
As a ﬁnal point, Mmy′s role as a Dpp signaling antagonist likely
extends beyond the embryonic epidermis and dorsal closure, as
Schimmelpfeng and coworkers have reported ectopic Dpp activity
in a mmy7 background in the Drosophila eye (Schimmelpfenget al., 2006). The failure in this study to detect ectopic dpp in the
epidermis of mutants likely reﬂects the low penetrance of dorsal
closure defects in the mmy7 background. We too are unable to
detect ectopic dpp in alleles with low penetrance of dorsal closure
defects. For raw mutants as well, there is a gradient of dpp
expansion that parallels the strength of molecularly characterized
loss-of-function alleles (Bates et al., 2008). Furthermore, this result
highlights the fact, that in terms of signaling, less gylcosyolation
does not necessarily correlate with more signaling; i.e. speciﬁc
thresholds of decreased gylcosylation/modiﬁcations might either
augment or limit signaling.Conclusions
During development, a surprisingly small number of signaling
cascades are used again and again to mediate communication
within and between cells, and to regulate a variety of cellular
responses, including proliferation, differentiation, survival, and
death. Among these essential signaling pathways are two (Dpp
and JNK) that we have studied here in the context of Drosophila
dorsal closure, and for which conserved functions have been
repeatedly demonstrated. In virtually all animal models, the Dpp
(TGF-β/BMP) pathways mediate both short- and long-range inter-
cellular communication in response to the eponymous, diffusible
extracellular cytokine. Similarly, the conserved JNK (MAPK)
G.B. Humphreys et al. / Developmental Biology 381 (2013) 434–445444pathways activate transcription of gene suites in virtually all
animal models in response to a variety of both extracellular and
intracellular stimuli, including peptide growth factors, cytokines,
and hormones, as well as diverse cellular stressors including
oxidative and endoplasmic reticulum stress. Deviation from the
strict control of any of these signaling pathways has been
implicated in the development of countless human developmental
abnormalities, degenerative diseases, and cancer pathologies. The
fact that health and development consequences of misregulated
signaling are so far-reaching has prompted numerous research
programs to seek a better understanding of how these complex
regulatory circuits are controlled - at the levels of both activation
and repression.
Approaching this problem by dissecting signaling circuitry in
the model genetic system of Drosophila dorsal closure, we have
made considerable progress in unraveling the complex circuitry
that links JNK to Dpp, and both to epithelial morphogenesis. Our
previous studies of raw have revealed its role as a master regulator
in the complex circuitry of the developing Drosophila embryo. Our
current studies of mmy reveal that UDP-N-acetylglucosamine
pyrophosphorylase activity is required to spatially limit Dpp
activity in a JNK/AP-1-independent fashion. Together, our studies
of the Drosophila Mmy and raw signaling antagonists lead us to a
fuller understanding of the molecular mechanisms governing
coordinated signaling pathways, which throughout the animal
kingdom control a variety of biologically essential cell growth,
proliferation, and differentiation pathways.Acknowledgments
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